Literature for aliskiren (A01.007 inhibitor)

(Topics flags: S Structure, T Target, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2018
1. Nakano,D. and Nishiyama,A.
   A novel role of renin inhibitor in the complement cascade
   Kidney Int94, 650-652. PubMed  Europe PubMed DOI  I
2015
2. Sun,X., Wen,X., Chen,Y.Y., Shi,C., Gao,C., Wu,Y., Wang,L.J., Yang,X.H. and Sun,H.
   Discovery of highly potent renin inhibitors potentially interacting with the S3' subsite of renin
   Eur J Med Chem103, 269-288. PubMed  Europe PubMed DOI  I
2011
3. Fisher,N.D. and Meagher,E.A.
   Renin inhibitors
   J Clin Hypertens (Greenwich)13, 662-666. PubMed  Europe PubMed DOI  I
2009
4. Kher,V.
   Renin inhibition - benefit beyond hypertension control
   J Assoc Physicians India57, 518-520. PubMed  Europe PubMed  I
5. Riccioni,G., Vitulano,N., D'Orazio,N. and Bellocci,F.
   Aliskiren, the first approved renin inhibitor: clinical application and safety in the treatment of hypertension
   Adv Ther26, 700-710. PubMed  Europe PubMed DOI  I
6. Sanoski,C.A.
   Aliskiren: an oral direct renin inhibitor for the treatment of hypertension
   Pharmacotherapy29, 193-212. PubMed  Europe PubMed DOI  I
2008
7. Dockery,B.K. and Bisognano,J.D.
   Direct renin inhibition: an analysis of possible benefits
   Curr Hypertens Rep10, 313-318. PubMed  Europe PubMed DOI  T  I
8. Jensen,C., Herold,P. and Brunner,H.R.
   Aliskiren: the first renin inhibitor for clinical treatment
   Nat Rev Drug Discov7, 399-410. PubMed  Europe PubMed DOI  I
2007
9. Dechend,R., Shagdarsuren,E., Gratze,P., Fiebeler,A., Pilz,B., Meiners,S., Derer,W., Feldman,D.L., Webb,R. and Muller,D.N.
   Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes
   J Renin Angiotensin Aldosterone Syst8, 81-84. PubMed  Europe PubMed DOI  I
10. Maibaum,J., Stutz,S., Goschke,R., Rigollier,P., Yamaguchi,Y., Cumin,F., Rahuel,J., Baum,H.P., Cohen,N.C., Schnell,C.R., Fuhrer,W., Gruetter,M.G., Schilling,W. and Wood,J.M.
    Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets
    J Med Chem50, 4832-4844. PubMed  Europe PubMed DOI  I
11. Pool,J.L.
    Direct renin inhibition: focus on aliskiren
    J Manag Care Pharm13, 21-33. PubMed  Europe PubMed  I
12. Van Tassell,B.W. and Munger,M.A.
    Aliskiren for renin inhibition: a new class of antihypertensives
    Ann Pharmacother41, 456-464. PubMed  Europe PubMed DOI  I
2006
13. Kalus,J.S.
    Aliskiren: a novel oral renin inhibitor for the treatment of hypertension
    Formulary41, 631-638.  I
14. Kushiro,T., Itakura,H., Abo,Y., Gotou,H., Terao,S. and Keefe,D.L.
    Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension
    Hypertens Res29, 997-1005. PubMed  Europe PubMed DOI  I
15. Luft,F.C.
    Achieving the goal of optimised renin system suppression: preclinical experience with a direct renin inhibitor
    J Renin Angiotensin Aldosterone Syst7 Suppl 2, S12-S15.  I
16. Muller,D.N. and Luft,F.C.
    Direct renin inhibition with aliskiren in hypertension and target organ damage
    Clin J Am Soc Nephrol1, 221-228. PubMed  Europe PubMed DOI  I
17. Staessen,J.A., Li,Y. and Richart,T.
    Oral renin inhibitors
    Lancet368, 1449-1456. PubMed  Europe PubMed DOI  I
2005
18. [YEAR:1-3-2005]Gradman,A.H., Schmieder,R.E., Lins,R.L., Nussberger,J., Chiang,Y. and Bedigian,M.P.
    Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients
    Circulation111, 1012-1018. PubMed  Europe PubMed DOI  I
19. Wood,J.M., Schnell,C.R., Cumin,F., Menard,J. and Webb,R.L.
    Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats
    J Hypertens23, 417-426. PubMed  Europe PubMed DOI  I
2003
20. [YEAR:5-9-2003]Wood,J.M., Maibaum,J., Rahuel,J., Grutter,M.G., Cohen,N.C., Rasetti,V., Ruger,H., Goschke,R., Stutz,S., Fuhrer,W., Schilling,W., Rigollier,P., Yamaguchi,Y., Cumin,F., Baum,H.P., Schnell,C.R., Herold,P., Mah,R., Jensen,C., O'Brien,E., Stanton,A. and Bedigian,M.P.
    Structure-based design of aliskiren, a novel orally effective renin inhibitor
    Biochem Biophys Res Commun308, 698-705. PubMed  Europe PubMed DOI  S  I